Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cell Reports. Medicine|September 8, 2022
Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older peopleHelen Parry, Rachel Bruton, Reni Ayodele, et al.Blood Advances|July 19, 2024
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GVHDKriti Verma, Wayne Croft, Sandra Margielewska-Davies, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2017
Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell TransplantationJustyna Ogonek, Kriti Verma, Christian Schultze-Florey, et al.JCI Insight|May 18, 2018
Unique features and clinical importance of acute alloreactive immune responsesCharlotte F Inman, Suzy A Eldershaw, Joanne E Croudace, et al.Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.Nature Aging|April 28, 2023
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infectionGokhan Tut, Tara Lancaster, Megan S Butler, et al.Nature Immunology|December 23, 2021
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infectionAlexander C Dowell, Megan S Butler, Elizabeth Jinks, et al.Pageof 2